|
|
||||||||
The Journal of Immunology, Vol 128, Issue 2 585-589, Copyright © 1982 by American Association of Immunologists
ARTICLES |
TW Chang, D Testa, PC Kung, L Perry, HJ Dreskin and G Goldstein
OKT3 monoclonal antibody, a human T cell mitogen, induced interferon production by cultured mononuclear cells at 10(-11) M concentrations. Interferon was secreted only under conditions wherein OKT3 was mitogenic, and production was correlated with cell proliferation. Thus, like mitogenesis, interferon secretion reached a peak 3 days after OKT3 stimulation, was inhibited by a factor(s) in human serum, and required 1000 times higher concentrations of Fab and F(ab')2 fragments of OKT3 for induction. The interferon was most likely of "gamma" (immune) type, because pH 2 and 56 degrees C treatments denatured it, whereas anti- alpha or -beta interferon antibodies did not. Mononuclear cells were fractionated into subpopulations that contained OKT4+ cells (helper/inducer T cells), OKT8+ cells (cytotoxic/suppressor T cells), and OKM1+ cells (monocytes) by combining sheep red blood cell rosetting and complement-mediated lysis using monoclonal antibodies against specific cell types. Both OKT4+ and OKT8+ cells proliferated upon OKT3 stimulation with the absolute requirement of OKM1+ cells. However, OKT4+ cells plus OKM1+ cells were necessary for the secretion of interferon. Studies with selective pretreatments with mitomycin C suggested that gamma-interferon was secreted by the OKT4+ cells and that the OKM1+ population subserved an accessory function.
This article has been cited by other articles:
![]() |
K Matsui, J. Boniface, P. Reay, H Schild, B Fazekas de St Groth, and M. Davis Low affinity interaction of peptide-MHC complexes with T cell receptors Science, December 20, 1991; 254(5039): 1788 - 1791. [Abstract] [PDF] |
||||
![]() |
E Celis and T. Chang Antibodies to hepatitis B surface antigen potentiate the response of human T lymphocyte clones to the same antigen Science, April 20, 1984; 224(4646): 297 - 299. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |